FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

119361006: Plasma specimen (specimen)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
180900016 Plasma specimen en Synonym Active Entire term case insensitive SNOMED CT core module
707016010 Plasma specimen (specimen) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1220466017 Plasma sample en Synonym Active Entire term case insensitive SNOMED CT core module

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plasma specimen Is a Acellular blood (serum or plasma) specimen true Inferred relationship Existential restriction modifier
Plasma specimen Specimen procedure Hematology false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Plasma true Inferred relationship Existential restriction modifier 1
Plasma specimen Specimen substance Blood false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Liquid substance false Inferred relationship Existential restriction modifier
Plasma specimen Is a Body fluid specimen true Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Blood false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Acellular blood false Inferred relationship Existential restriction modifier 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Mass concentration of apolipoprotein A2 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of cyclosporin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of thyroxine binding globulin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of thyroglobulin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of selenium in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of methylmalonate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 2 receptor antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of isoleucine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of pristanate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of levetiracetam in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of GQ1b ganglioside antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of high molecular weight kininogen in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of methylglutaryl in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of vitamin B2 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of proinsulin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 1,25-dihydroxy vitamin D3 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of vitamin B1 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement component C5 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of valine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of tetradecadienoylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of homocystine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-hydroxybutyrate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of taurine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of manganese in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of flecainide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of fructosamine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Qualitative result of Cytomegalovirus antigen in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of maltose in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of D-dimer in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Percent of activated protein C with factor V deficient plasma in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of ornithine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of arsenic in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of vitamin K in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of amitriptyline in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of cis-4-decenoate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of lorazepam in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of cholestanol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of catecholamine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of C-terminal telopeptide collagen type 1 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of glutamine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of oleylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of creatine to guanidinoacetate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of coagulation factor IX in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of hexacosanoate (C26) to docosanoate (C22) in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of titanium in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Fasting mass concentration of beta-carboxy-terminal telopeptide of type I collagen in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of glucagon like peptide-1 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of diethylene glycol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of normetadrenaline in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of carnitines, total to free in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Catalytic activity of beta-hexosaminidase B in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of insulin-like growth factor 2 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of homocysteine, free in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement factor H in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of C-terminal glucagon in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of lamotrigine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Catalytic activity of biotinidase in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-methylcrotonylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of pancreastatin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of warfarin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of boron in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of free carnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Percent fraction of functional complement 1 esterase inhibitor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of aetiocholanolone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of zinc in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Qualitative result of fungal precipitin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of desethylamiodarone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of lactate dehydrogenase in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of inhibin B in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of free testosterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of testosterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement 1 esterase inhibitor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of glutarylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of creatine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of erythropoietin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of clomipramine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of cortisol, free in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of cholesterol to low density lipoprotein in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of coagulation factor VIII inhibitor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of dexamethasone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of chromium in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Catalytic activity of acid phosphatase in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of sulphonylurea in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of molybdenum in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 2-methylbutyrylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of fructose in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of coagulation factor IX inhibitor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of methylenedioxymethamphetamine (ecstasy) in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of codeine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of ethanolamine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of unconjugated bilirubin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of free carbamazepine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Ratio of free protein S to total protein S in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of sex hormone binding globulin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of insulin-like growth factor 1 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of follicle stimulating hormone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of total iron binding capacity in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of phytanate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Qualitative result of Cytomegalovirus early antigen in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-methoxytyramine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of morphine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1

Start Previous Page 6 of 8 Next End

This concept is not in any reference sets

Back to Start